๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Occurrence of colon adenocarcinoma in chronic myeloid leukemia patients treated with imatinib: Report of two cases and review of the literature

โœ Scribed by A. Frustaci; M. Breccia; L. Cannella; C. Stefanizzi; G. Alimena


Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
74 KB
Volume
33
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Is it possible to discontinue imatinib m
โœ Salvatore Guastafierro; Umberto Falcone; Maria Celentano; Milena Coppola; Maria ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 111 KB

Imatinib mesylate (IM) therapy leads to a complete cytogenetic response (CCyR) in 75-90% of Chronic Myeloid Leukemia (CML) patients in chronic phase, but only a small percentage of patients achieve complete molecular response (CMR). Very little is known about IM discontinuation. We report the case o